Paras Healthcare Valuation Multiples

Paras Healthcare is valued at $960M as of November 2026, a 6.3x revenue multiple. In the last fiscal year, Paras Healthcare revenue was $172M and Paras Healthcare EBITDA was $34M.

Paras Healthcare Overview

About Paras Healthcare

Paras Healthcare Ltd is mainly engaged in the business of providing healthcare services. The company has single business segment Healthcare services. The company is operating in India which constitutes a single geographical segment. Its specialities are Cardiac Sciences, Onco Care, Neuro Sciences, Gastro Sciences, Orthopaedics, Obstetrics & Gynaecology, Renal Sciences, General Surgery, Plastic Surgery, Dermatology & Cosmetology, ENT, Neck & Head Surgery, Internal Medicine, Dentistry, Clinical Psychology, Psychiatry, Critical Care, Pulmonology, Paediatrics, Emergency Medicine, Endocrinology, Liver Transplant & Gl Surgery.


Founded

1987

HQ

India

Employees

N/A

Financials (Last FY)

Revenue: $172M
EBITDA: $34M

EV

$1.1B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Paras Healthcare Financials

Paras Healthcare reported last fiscal year revenue of $172M and EBITDA of $34M.

In the same fiscal year, Paras Healthcare generated $61M in gross profit, $34M in EBITDA, and $5M in net income.


Paras Healthcare P&L

In the most recent fiscal year, Paras Healthcare reported revenue of $172M and EBITDA of $34M.

Paras Healthcare is profitable as of last fiscal year, with gross margin of 35%, EBITDA margin of 20%, and net margin of 3%.

See analyst estimates for Paras Healthcare
Last FY202620272028
Revenue$172M
Gross Profit$61M
Gross Margin35%
EBITDA$34M
EBITDA Margin20%
EBIT Margin11%
Net Profit$5M
Net Margin3%
Net Debt$91M

Financial data powered by Morningstar, Inc.

Paras Healthcare Stock Performance

Paras Healthcare has current market cap of $960M, and enterprise value of $1.1B.


Paras Healthcare's stock price is $8.87.

Paras Healthcare has an EPS (earnings per share) of $0.04.

See more trading valuation data for Paras Healthcare
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$1.1B$960M-5.8%---$0.04

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Paras Healthcare Valuation Multiples

Paras Healthcare trades at 6.3x EV/Revenue multiple, and 32.3x EV/EBITDA.

See NTM and 2027E valuation multiples for Paras Healthcare

Paras Healthcare Financial Valuation Multiples

As of November 19, 2026, Paras Healthcare has market cap of $960M and EV of $1.1B.

Paras Healthcare has a P/E ratio of 204.5x.

Last FY202620272028
EV/Revenue6.3x
EV/EBITDA32.3x
EV/EBIT57.9x
EV/Gross Profit17.8x
P/E204.5x
EV/FCF(88.4x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Paras Healthcare Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Paras Healthcare Margins & Growth Rates

Paras Healthcare grew revenue by 20% and EBITDA by 37% in the last fiscal year.

In the most recent fiscal year, Paras Healthcare reported gross margin of 35%, EBITDA margin of 20%, and net margin of 3%.

See estimated margins and future growth rates for Paras Healthcare

Paras Healthcare Margins

Last FY2026202720282029
Gross Margin35%-
EBITDA Margin20%22%
EBIT Margin11%13%
Net Margin3%8%
FCF Margin(7%)-

Paras Healthcare Growth Rates

FY+1/FY26/2727/2828/29
Revenue Growth20%
EBITDA Growth37%
EBIT Growth45%
Net Profit Growth310%

Data powered by FactSet, Inc. and Morningstar, Inc.

Paras Healthcare Operational KPIs

Access forward-looking KPIs for Paras Healthcare
Last FY202620272028
S&M Expenses to Revenue2%
Opex to Revenue25%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Paras Healthcare Competitors

Paras Healthcare competitors include HealthCare Global Enterprises, Ramsay Santé, Infracore, Al Hammadi Holding, Clinica Baviera, Thomson Medical, Jupiter Life Line, Life Healthcare Group, Med Life and Dr. Sulaiman Al Habib Medical Services.

Most Paras Healthcare public comparables operate across Hospitals & Clinics.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
HealthCare Global Enterprises$270M$45M4.2x3.8x24.7x20.7x
Ramsay Santé$5.9B$658M0.9x-7.8x-
Infracore$29K-37194.4x---
Al Hammadi Holding$329M$98M3.0x2.8x10.1x11.3x
Clinica Baviera$332M$93M2.9x2.6x10.2x9.2x
Thomson Medical$326M$52M5.5x5.2x34.0x25.5x
Jupiter Life Line$161M$37M6.5x5.9x28.1x26.7x
Life Healthcare Group$1.5B$52M0.9x0.9x25.0x5.5x

This data is available for Pro users. Sign up to see all Paras Healthcare competitors and their valuation data.

Start Free Trial

Paras Healthcare VC Funding History

Before going public, Paras Healthcare raised $64M in total equity funding, across 3 rounds.


Paras Healthcare Funding Rounds

DateStageInvestorsRaisedValuationRev. MultipleDeal Summary
Jun-25Undisclosed stage360 ONE Asset$20M-Paras Healthcare is a leading multispecialty hospital chain in North India, founded by Dr. Dharminder Nagar, operating more than 2,000 beds across eight hospitals in Tier 1 and Tier 2 cities. The group emphasizes accessible, high-quality medical care with affordability, supported by an asset-light business model and strong unit economics. On June 4, 2025, 360 ONE Asset, a wholly-owned subsidiary of 360 ONE WAM, completed an investment of INR 170.60 crore in Paras Healthcare. This transaction included both primary capital infusion to support growth and a secondary component with a partial exit by an existing investor. The investment marks 360 ONE Asset's seventh in the Indian healthcare services segment, aligning with its market-leading Pre-IPO strategy. Umesh Agrawal, Senior Fund Manager and Strategy Head for Financial Services and Industrials at 360 ONE Asset, highlighted the firm's conviction in the sector's long-term potential and commitment to partnering with Paras Healthcare to expand affordable quality care to underserved customers. 360 ONE Asset manages significant assets, with its Venture Capital and Private Equity platform overseeing over USD 3 billion focused on healthcare, technology, financial services, and consumer industries. No financial metrics such as post-money valuation, revenue, ARR, EBITDA, or valuation multiples were disclosed in the announcements. The funding is positioned to aid Paras Healthcare's expansion in delivering healthcare services in under-served areas of North India.
Apr-25Seed-$3M-Paras Healthcare Limited operates as the fifth largest healthcare provider in North India, Bihar, and Jharkhand by bed capacity, with 2,135 beds as of March 31, 2024. The company offers clinical specialties including cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics, and joint replacement, which accounted for 72.34% of revenue from operations in Fiscal 2024. It plans a public IPO with a fresh issue of ₹400 crores and sale of 14,974,010 existing equity shares. Financials for Fiscal 2024 show revenue from operations of ₹1,129.039 crores, alongside peers reporting significantly higher figures like ₹19,059.2 crores and ₹6,892.92 crores. EPS stands at (1.57), with negative Return on Net Worth of (8.63)% and NAV per share of ₹3.468. The IPO prospectus notes an EBITDA margin of 13.68%, ROE of -4.53%, and ROA of -1.04%. Creador-backed Paras Healthcare revived its IPO plan in March 2026, aiming to raise around $200 million, with optimism for growth in smaller northern Indian cities through its Patna hospital and diversified operations.
Jul-17Undisclosed stageCreador$42M-Paras Healthcare, a Gurgaon-based healthcare provider founded in 2006 by Dharminder Nagar, operates hospitals offering tertiary care and specialized mother-and-child services across North India, including locations in Gurgaon, Patna, Darbhanga, Panchkula, and New Delhi, with 730 beds at the time of the investment. The company raised $42 million (Rs 275 crore or RM180 million) in July 2017 from an affiliate of private equity firm Creador III LP (Commelina Ltd), marking its debut PE round, advised by Avendus Capital with Khaitan & Co as legal counsel. Funds were earmarked for expansion, including adding over 1,000 beds through greenfield projects, leases, and acquisitions over the next few years, targeting underserved Tier II and III towns in North India where healthcare penetration is low. Creador acquired a minority stake, later specified as approximately 25% or precisely 24.68% after conversion of Compulsorily Convertible Preference Shares (CCPS) to equity in September 2018. The investment highlighted Paras's focus on affordable, quality super-specialty care for the middle class in regions like Bihar, amid India's underserved healthcare market with only nine beds per 10,000 population versus a global average of 30, and rising private sector involvement in a $160 billion expenditure growing at 17% CAGR. Recent developments include plans for a Rs 1000-1200 crore IPO in 2024, primarily for Creador's exit via secondary sale, with a prospective valuation of Rs 3500-4500 crore, and FY23 revenue of Rs 918 crore up 17% from FY22, driven by segments like cancer care, orthopedics, cardiology, and neurosurgery.

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Paras Healthcare

When was Paras Healthcare founded?Paras Healthcare was founded in 1987.
Where is Paras Healthcare headquartered?Paras Healthcare is headquartered in India.
Is Paras Healthcare publicly listed?Yes, Paras Healthcare is a public company listed on Bombay Stock Exchange.
What is the stock symbol of Paras Healthcare?Paras Healthcare trades under 545005 ticker.
When did Paras Healthcare go public?Paras Healthcare went public in 2026.
Who are competitors of Paras Healthcare?Paras Healthcare main competitors include HealthCare Global Enterprises, Ramsay Santé, Infracore, Al Hammadi Holding, Clinica Baviera, Thomson Medical, Jupiter Life Line, Life Healthcare Group, Med Life, Dr. Sulaiman Al Habib Medical Services.
What is the current market cap of Paras Healthcare?Paras Healthcare's current market cap is $960M.
What is the current revenue of Paras Healthcare?Paras Healthcare's last fiscal year revenue is $172M.
What is the current revenue growth of Paras Healthcare?Paras Healthcare revenue growth (vs. last FY) is 20%.
What is the current EV/Revenue multiple of Paras Healthcare?Current revenue multiple of Paras Healthcare is 6.3x.
Is Paras Healthcare profitable?No, Paras Healthcare is not profitable.
How many companies Paras Healthcare has acquired to date?Paras Healthcare hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Paras Healthcare has invested to date?Paras Healthcare hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Paras Healthcare

Lists including Paras Healthcare

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial